Meta分析：EGFR阳性非小细胞肺癌EGFR TKI耐药者免疫检查点抑制剂ICI的有效性

杨学宁医师 · 发表于 2024-3-5 00:10:22

您需要登录才可以下载或查看，没有账号？立即注册

×

Efficacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis - PubMed (nih.gov)

Qian X, Guo X, Li T, Hu W, Zhang L, Wu C, Ye F. Efficacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis. Front Pharmacol. 2022 Aug 22;13:926890. doi: 10.3389/fphar.2022.926890. PMID: 36071838; PMCID: PMC9442341.

微信扫二维码转发分享

账号		自动登录	找回密码
密码			立即注册

[不可手术有驱动] Meta分析：EGFR阳性非小细胞肺癌EGFR TKI耐药者免疫检查点抑制剂ICI的有效性